Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Syros Pharmaceuticals (SYRS)
NASDAQ:SYRS
RESEARCH TOOLSreports
Holding SYRS?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | - | - | $ 387.00K | $ 3.76M |
| Gross Profit | - | - | - | $ 387.00K | $ 3.76M |
| EBIT | $ -6.40M | $ -21.95M | $ -2.40M | $ -63.05M | $ -40.14M |
| EBITDA | $ -5.92M | $ -21.38M | $ -2.03M | $ -62.70M | $ -39.39M |
| Net Income Common Stockholders | $ -6.40M | $ -23.33M | $ -3.71M | $ -64.38M | $ -40.14M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 58.27M | $ 78.96M | $ 108.30M | $ 139.53M | $ 112.22M |
| Total Assets | $ 85.00M | $ 106.72M | $ 134.73M | $ 168.17M | $ 147.79M |
| Total Debt | $ 60.23M | $ 60.66M | $ 61.67M | $ 62.08M | $ 62.46M |
| Net Debt | $ 1.95M | $ -18.30M | $ -46.63M | $ -77.45M | $ -49.76M |
| Total Liabilities | $ 96.12M | $ 113.07M | $ 119.67M | $ 151.51M | $ 111.49M |
| Stockholders Equity | $ -11.12M | $ -6.31M | $ 15.06M | $ 16.66M | $ 36.30M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -20.69M | $ -29.67M | $ -31.10M | $ -18.60M | $ -31.86M |
| Operating Cash Flow | $ -20.69M | $ -29.67M | $ -31.10M | $ -18.56M | $ -31.86M |
| Investing Cash Flow | - | $ 25.07M | $ -24.64M | $ 1.52M | $ 28.64M |
| Financing Cash Flow | - | $ 41.00K | $ -265.00K | $ 43.38M | $ -5.00K |